Product Information
CYCLOBENZAPRINE ER 30 MG CAP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.8887 per EA under NDC 00093192106. Its NADAC has been published 115 times since Apr 17, 2024.
The High Outlier badge above means this manufacturer's average price in the Cyclobenzaprine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093192106
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021777On Market Since
3/4/2019
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE ER 30 MG CAP has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 52.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8887 per EA |
|---|---|
| All-time high | $2.7621 (Jan 14, 2026) |
| All-time low | $0.8448 (Mar 18, 2026) |
| 52-week high | $2.7621 |
| 52-week low | $0.8448 |
| Median price | $2.7613 |
| Average price | $2.1002 |
| Largest weekly change | -69.0% (Jan 21, 2026) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE ER 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE ER 30 MG CAP, manufactured by Teva Pharmaceuticals USA Inc., is $0.8887 per EA (NDC 00093192106), effective Jun 24, 2026.
How has the price of CYCLOBENZAPRINE ER 30 MG CAP changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE ER 30 MG CAP has declined 52.1%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE ER 30 MG CAP?
Since Apr 17, 2024, the NADAC for CYCLOBENZAPRINE ER 30 MG CAP has ranged from a low of $0.8448 (Mar 18, 2026) to a high of $2.7621 (Jan 14, 2026), with a median of $2.7613 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE ER 30 MG CAP?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CYCLOBENZAPRINE ER 30 MG CAP, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE ER 30 MG CAP?
CYCLOBENZAPRINE ER 30 MG CAP (NDC 00093192106) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification